These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 37456173)

  • 1. Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study.
    Oladapo A; Kolodny S; Vredenburg M; Swallow E; Goldschmidt D; Sarathy K; Lopez P; Maitland H; Yee J
    Ther Adv Hematol; 2023; 14():20406207231179856. PubMed ID: 37465395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eltrombopag plus cyclosporine in refractory immune thrombocytopenia: a single-center study.
    Hong Y; Shen Y; Liu Q; Dong J; Xiang J; Shen Y; Wu L; Zhou Y; Ye B; Wu D
    Res Pract Thromb Haemost; 2023 Jul; 7(5):100279. PubMed ID: 37456916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missing Cells-A Rare Case of Persisting Thrombocytopenia in Pregnancy With Dengue and Role of Romiplostim in These Cases.
    Sinha R; Datta MR; Singh V
    J Family Reprod Health; 2023 Jun; 17(2):105-108. PubMed ID: 37547782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term use of eltrombopag in children with chronic immune thrombocytopenia: extended real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology.
    Giordano P; Lassandro G; Barone A; Cesaro S; Fotzi I; Giona F; Gorio C; Maggio A; Miano M; Marzollo A; Nardi M; Pession A; Ruggiero A; Russo G; Saracco P; Spinelli M; Tolva A; Tornesello A; Palladino V; Del Vecchio GC
    Front Med (Lausanne); 2023; 10():1214308. PubMed ID: 37521342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.
    Shao X; Xu P; Ji L; Wu B; Zhan Y; Zhuang X; Ou Y; Hua F; Sun L; Li F; Wang X; Chen H; Cheng Y
    Clin Transl Med; 2023 Jul; 13(7):e1344. PubMed ID: 37488670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease.
    Wang H; He G; Jia J; Liu M; Liu H; Wang T; Liu C; Fu R
    J Transl Int Med; 2023 Mar; 11(1):90-93. PubMed ID: 37533842
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity is associated with poor outcomes of corticosteroid treatment in patients with primary immune thrombocytopenia.
    Zhang X; Liu Q; Liu A; Leng S; Wang X; Zhao R; Sheng Z; Feng Q; Yang X; Wang S; Hou M; Peng J; Feng G
    Br J Haematol; 2023 Oct; 203(2):295-303. PubMed ID: 37488467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a meta-analysis.
    Chen W; Liu Y; Li L; Zeng X
    BMC Pharmacol Toxicol; 2023 Dec; 24(1):71. PubMed ID: 38041150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of non‑peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta‑analysis of short‑term double‑blind randomized clinical trials.
    Shen N; Qiao J; Jiang Y; Yin H; Li M; Zhu S; Li J
    Exp Ther Med; 2023 Aug; 26(2):393. PubMed ID: 37456173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials.
    Shen N; Qiao J; Jiang Y; Yan J; Wu R; Yin H; Zhu S; Li J
    Biomed Rep; 2024 Mar; 20(3):44. PubMed ID: 38357229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review.
    Birocchi S; Podda GM; Manzoni M; Casazza G; Cattaneo M
    Platelets; 2021 Feb; 32(2):216-226. PubMed ID: 32281449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study.
    Sheng XY; Liu ZY; Zhao J; Song L; Zhao WM; Zhao X; Cui YM
    Platelets; 2022 Nov; 33(8):1185-1191. PubMed ID: 35549802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of thrombopoietin receptor agonists in children and adults with persistent and chronic immune thrombocytopenia: a meta-analysis.
    Li T; Liu Q; Pu T; Liu J; Zhang A
    Expert Opin Pharmacother; 2023 Apr; 24(6):763-774. PubMed ID: 37010022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral venous sinus thrombosis in immune thrombocytopenia patients treated with thrombopoietin receptor agonist: Case reports and literature review.
    Teekaput C; Nadsasarn A; Tanprawate S; Soontornpun A; Thiankhaw K; Wantaneeyawong C; Teekaput K; Chai-Adisaksopha C
    Ann Med Surg (Lond); 2022 Jul; 79():104116. PubMed ID: 35860055
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.